Abstract
Observational studies indicate that periodontal disease may increase the risk of colorectal, lung, and pancreatic cancers. We tested these associations using two-sample Mendelian randomization to emulate a randomized study with observational data. We developed an instrument including single nucleotide polymorphisms with strong genome-wide association study evidence for associations with aggressive and/or advanced periodontal disease. We used this instrument to assess associations with summary-level genetic data for colorectal cancer (n=58,131 cases), lung cancer (n=18,082 cases), and pancreatic cancer (n=9254 cases). The genetic predisposition index for periodontitis was significantly associated with an increased risk of colorectal cancer (p=0.026), colon cancer (p=0.021), proximal colon cancer (p=0.013), and colorectal cancer among females (p=0.039); however, it was not significantly associated with the risk of lung cancer or pancreatic cancer, overall or within most subgroups. Further research should determine whether increased periodontitis prevention and increased cancer surveillance of patients with periodontitis is warranted.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported the AACR-Johnson & Johnson Lung Cancer Innovation Science Grant Number 18-90-52-MICH. Laura Corlin was supported by the National Institute of Child Health & Human Development at the National Institutes of Health (grant number K12HD092535). Konstantinos K Tsilidis is supported by Cancer Research UK (grant number: C18281/A29019). Christopher Amos is a Research Scholar supported by Cancer Prevention Research Institute of Texas grant RR170048.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Consortium nameEthics Committee / Institutional Review Board (IRB) Decision made by ethical oversight body PanScan studiesNCI Special Studies IRB (SSIRB)Approved under secondary aims PanC4 IRB of Johns Hopkins MedicineWaived (de-identified data) ILCCOIRB of Baylor College of MedicineWaived (de-identified data) GECCOIRB of Fred Hutchinson Cancer Research CenterApproved CCFRIRB of Fred Hutchinson Cancer Research CenterApproved CCFRMount Sinai Hospital Research Ethics BoardApproved CCFRUniversity of Hawaii Human Studies ProgramApproved CCFRUniversity of Melbourne Health Sciences Human Ethics Sub-CommitteeApproved CCFRMayo Clinic IRBApproved CCFRCSMC Institutional Review BoardsApproved CORECTIRB of University of Southern California Health SciencesApproved
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
laura.corlin{at}tufts.edu
mengyuan.ruan{at}tufts.edu
ktsilidis{at}gmail.com
ebouras{at}gapps.auth.gr
Yau-Hua.Yu{at}tufts.edu
stolzenr{at}dcpcepn.nci.nih.gov
aklein1{at}jhmi.edu
harvey.risch{at}yale.edu
chrisa{at}bcm.edu
lori.sakoda{at}kp.org
pavel.vodicka{at}iem.cas.cz
pai.rish{at}mayo.edu
James_beck{at}unc.edu
eplatz1{at}jhu.edu
Dominique.Michaud{at}tufts.edu
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.